AI In Oncology Market Size, Share & Trends Analysis Report By Component (Software Solutions, Hardware, Services), By Cancer Type, By Treatment Type, By Region, And Segment Forecasts, 2022 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation and Scope
                   1.2. Market Definition
                   1.3. Research Methodology
                       1.3.1. Information Procurement
                           1.3.1.1. Purchased database
                           1.3.1.2. GVR’s internal database
                       1.3.2. Primary Research
                   1.4. Research Scope and Assumptions
                   1.5. List to Data Sources
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Competitive Insights
                   2.4. AI in Oncology Market
Chapter 3. AI in Oncology Market Variables, Trends, & Scope
                   3.1. Penetration and Growth Prospect Mapping
                   3.2. Market Dynamics
                   3.3. AI in Oncology Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Bargaining power of the suppliers
                           3.3.1.2. Bargaining power of the buyers
                           3.3.1.3. Threats of substitution
                           3.3.1.4. Threats from new entrants
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Economic and Social landscape
                           3.3.2.3. Technological landscape
                       3.3.3. Impact of COVID-19 on the market
Chapter 4. Chapter 5 AI in Oncology Market: Component Estimates & Trend Analysis
                   4.1. Definitions & Scope
                   4.2. AI in Oncology Market: Component Movement Analysis, 2021 & 2030 (USD Million)
                   4.3. Software Solutions
                       4.3.1. Software Solutions market estimates and forecasts, 2016 - 2030 (USD Million)
                   4.4. Hardware
                       4.4.1. Hardware market estimates and forecasts, 2016 - 2030 (USD Million)
                   4.5. Services
                       4.5.1. Services market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 5. AI in Oncology Market: Cancer Type Estimates & Trend Analysis
                   5.1. Definitions and Scope
                   5.2. AI in Oncology Market: Cancer Type Movement Analysis, 2021 & 2030 (USD Million)
                   5.3. Breast Cancer
                       5.3.1. Breast Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
                   5.4. Lung Cancer
                       5.4.1. Lung Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
                   5.5. Prostate Cancer
                       5.5.1. Prostate Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
                   5.6. Colorectal Cancer
                       5.6.1. Colorectal Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
                   5.7. Brain Tumor
                       5.7.1. Brain Tumor market estimates and forecasts, 2016 - 2030 (USD Million)
                   5.8. Others
                       5.8.1. Others market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 6. AI in Oncology Market: Treatment Type Estimates & Trend Analysis
                   6.1. Definitions & Scope
                   6.2. AI in Oncology Market: Treatment Type Movement Analysis, 2021 & 2030 (USD Million)
                   6.3. Chemotherapy
                       6.3.1. Chemotherapy market estimates and forecasts, 2016 - 2030 (USD Million)
                   6.4. Radiotherapy
                       6.4.1. Radiotherapy market estimates and forecasts, 2016 - 2030 (USD Million)
                   6.5. Immunotherapy
                       6.5.1. Immunotherapy market estimates and forecasts, 2016 - 2030 (USD Million)
                   6.6. Others
                       6.6.1. Others market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 7. AI in Oncology Market: Regional Estimates & Trend Analysis
                   7.1. Regional Market Snapshot
                   7.2. AI in Oncology Market: Regional Movement Analysis
                   7.3. North America
                       7.3.1. North America market estimates and forecasts, by component 2016 - 2030 (USD Million)
                       7.3.2. North America market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                       7.3.3. North America market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.3.4. U.S.
                           7.3.4.1. U.S. market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.3.4.2. U.S. market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.3.4.3. U.S. market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.3.5. Canada
                           7.3.5.1. Canada market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.3.5.2. Canada market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.3.5.3. Canada market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                   7.4. Europe
                       7.4.1. Europe market estimates and forecasts, by component 2016 - 2030 (USD Million)
                       7.4.2. Europe market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                       7.4.3. Europe market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.4.4. Germany
                           7.4.4.1. Germany market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.4.4.2. Germany market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.4.4.3. Germany market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.4.5. U.K.
                           7.4.5.1. U.K. market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.4.5.2. U.K. market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.4.5.3. U.K. market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.4.6. France
                           7.4.6.1. France market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.4.6.2. France market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.4.6.3. France market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.4.7. Italy
                           7.4.7.1. Italy market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.4.7.2. Italy market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.4.7.3. Italy market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.4.8. Spain
                           7.4.8.1. Spain market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.4.8.2. Spain market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.4.8.3. Spain market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.4.9. Russia
                           7.4.9.1. Russia market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.4.9.2. Russia market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.4.9.3. Russia market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                   7.5. Asia Pacific
                       7.5.1. Asia Pacific market estimates and forecasts, by component 2016 - 2030 (USD Million)
                       7.5.2. Asia Pacific market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                       7.5.3. Asia Pacific market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.5.4. Japan
                           7.5.4.1. Japan market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.5.4.2. Japan market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.5.4.3. Japan market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.5.5. China
                           7.5.5.1. China market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.5.5.2. China market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.5.5.3. China market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.5.6. India
                           7.5.6.1. India market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.5.6.2. India market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.5.6.3. India market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.5.7. Australia
                           7.5.7.1. Australia market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.5.7.2. Australia market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.5.7.3. Australia market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.5.8. South Korea
                           7.5.8.1. South Korea market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.5.8.2. South Korea market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.5.8.3. South Korea market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                   7.6. Latin America
                       7.6.1. Latin America market estimates and forecasts, by component 2016 - 2030 (USD Million)
                       7.6.2. Latin America market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                       7.6.3. Latin America market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.6.4. Brazil
                           7.6.4.1. Brazil market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.6.4.2. Brazil market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.6.4.3. Brazil market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.6.5. Mexico
                           7.6.5.1. Mexico market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.6.5.2. Mexico market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.6.5.3. Mexico market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.6.6. Argentina
                           7.6.6.1. Argentina market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.6.6.2. Argentina market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.6.6.3. Argentina market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                   7.7. MEA
                       7.7.1. MEA market estimates and forecasts, by component 2016 - 2030 (USD Million)
                       7.7.2. MEA market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                       7.7.3. MEA market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.7.4. South Africa
                           7.7.4.1. South Africa market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.7.4.2. South Africa market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.7.4.3. South Africa market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.7.5. Saudi Arabia
                           7.7.5.1. Saudi Arabia market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.7.5.2. Saudi Arabia market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.7.5.3. Saudi Arabia market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
                       7.7.6. UAE
                           7.7.6.1. UAE market estimates and forecasts, by component 2016 - 2030 (USD Million)
                           7.7.6.2. UAE market estimates and forecasts, by cancer type 2016 - 2030 (USD Million)
                           7.7.6.3. UAE market estimates and forecasts, by treatment type 2016 - 2030 (USD Million)
Chapter 8. AI in Oncology Market - Competitive Analysis
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Competition Categorization
                   8.3. Company Market Position Analysis
Chapter 9. Competitive Landscape: Company Profiles
                   9.1. Azra AI
                       9.1.1. Company overview
                       9.1.2. Financial performance
                       9.1.3. Product benchmarking
                       9.1.4. Strategic initiatives
                   9.2. IBM
                       9.2.1. Company overview
                       9.2.2. Financial performance
                       9.2.3. Product benchmarking
                       9.2.4. Strategic initiatives
                   9.3. Siemens Healthineers
                       9.3.1. Company overview
                       9.3.2. Financial performance
                       9.3.3. Product benchmarking
                       9.3.4. Strategic initiatives
                   9.4. Intel
                       9.4.1. Company overview
                       9.4.2. Financial performance
                       9.4.3. Product benchmarking
                       9.4.4. Strategic initiatives
                   9.5. GE Healthcare
                       9.5.1. Company overview
                       9.5.2. Financial performance
                       9.5.3. Product benchmarking
                       9.5.4. Strategic initiatives
                   9.6. NVIDIA
                       9.6.1. Company overview
                       9.6.2. Financial performance
                       9.6.3. Product benchmarking
                       9.6.4. Strategic initiatives
                   9.7. Digital Diagnostics Inc.
                       9.7.1. Company overview
                       9.7.2. Financial performance
                       9.7.3. Product benchmarking
                       9.7.4. Strategic initiatives
                   9.8. Concert.AI
                       9.8.1. Company overview
                       9.8.2. Financial performance
                       9.8.3. Product benchmarking
                       9.8.4. Strategic initiatives
                   9.9. Median Technologies
                       9.9.1. Company overview
                       9.9.2. Financial performance
                       9.9.3. Product benchmarking
                       9.9.4. Strategic initiatives
                   9.10. Path AI
                       9.10.1. Company overview
                       9.10.2. Financial performance
                       9.10.3. Product benchmarking
                       9.10.4. Strategic initiatives

List of Tables

Table 1 Factors used in segment share estimation
Table 2 List of secondary data sources
Table 3 Primary interview details, by source
Table 4 Primary interview details, by region
Table 5 North America market estimates and forecasts, by country, 2016 - 2030 (USD Million)
Table 6 North America market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 7 North America market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 8 North America market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 9 U.S. market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 10 U.S. market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 11 U.S. market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 12 Canada market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 13 Canada market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 14 Canada market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 15 Europe market estimates and forecasts, by country, 2016 - 2030 (USD Million)
Table 16 Europe market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 17 Europe market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 18 Europe market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 19 Germany market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 20 Germany market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 21 Germany market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 22 U.K. market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 23 U.K. market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 24 U.K. market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 25 France market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 26 France market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 27 Italy market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 28 Italy market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 29 Italy market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 30 Spain market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 31 Spain market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 32 Spain market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 33 Russia market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 34 Russia market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 35 Russia market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 36 Asia Pacific market estimates and forecasts, by country, 2016 - 2030 (USD Million)
Table 37 Asia Pacific market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 38 Asia Pacific market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 39 Asia Pacific market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 40 Japan market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 41 Japan market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 42 Japan market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 43 China market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 44 China market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 45 China market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 46 India market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 47 India market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 48 India market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 49 Australia market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 50 Australia market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 51 Australia market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 52 Singapore market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 53 Singapore market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 54 Singapore market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 55 South Korea market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 56 South Korea market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 57 South Korea market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 58 Latin America market estimates and forecasts, by country, 2016 - 2030 (USD Million)
Table 59 Latin America market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 60 Latin America market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 61 Latin America market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 62 Brazil market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 63 Brazil market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 64 Brazil market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 65 Mexico market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 66 Mexico market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 67 Mexico market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 68 Argentina market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 69 Argentina market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 70 Argentina market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 71 MEA market estimates and forecasts, by country, 2016 - 2030 (USD Million)
Table 72 MEA market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 73 MEA market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 74 MEA market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 75 South Africa market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 76 South Africa market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 77 South Africa market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 78 Saudi Arabia market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 79 Saudi Arabia market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 80 Saudi Arabia market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)
Table 81 UAE market estimates and forecasts, by component, 2016 - 2030 (USD Million)
Table 82 UAE market estimates and forecasts, by cancer type, 2016 - 2030 (USD Million)
Table 83 UAE market estimates and forecasts, by treatment type, 2016 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data Triangulation Techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market Snapshot
Fig. 9 AI in Oncology Market variables, trends & scope
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 Technology Timeline (Transition / various technology adoption past & future predictions)
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Company/Competition Categorization
Fig. 15 Company market position analysis
Fig. 16 Component market share analysis, 2021 & 2030
Fig. 17 Segment Dashboard
Fig. 18 Software Solutions market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 19 Hardware market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 20 Services market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 21 Cancer type market share analysis, 2021 & 2030
Fig. 22 Segment Dashboard
Fig. 23 Breast Cancer market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 24 Lung Cancer market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 25 Prostate Cancer market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 26 Colorectal Cancer market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 27 Brain Tumor market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 28 Others market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 29 Treatment type market share analysis, 2021 & 2030
Fig. 30 Segment Dashboard
Fig. 31 Chemotherapy market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 32 Radiotherapy market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 33 Immunotherapy market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 34 Others market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 35 Regional market place: Key takeaways
Fig. 36 AI in Oncology Market: Regional outlook, 2021 & 2030 (USD Million)
Fig. 37 North America market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 38 U.S. market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 39 Canada market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 40 Europe market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 41 Germany market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 42 U.K. market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 43 France market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 44 Italy market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 45 Spain market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 46 Russia market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 47 Asia Pacific market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 48 Japan market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 49 China market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 50 India market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 51 Australia market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 52 South Korea market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 53 Latin America market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 54 Brazil market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 55 Mexico market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 56 Argentina market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 57 MEA market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 58 South Africa market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 59 Saudi Arabia market revenue estimates and forecasts, 2016 - 2030 (USD Million)
Fig. 60 UAE market revenue estimates and forecasts, 2016 - 2030 (USD Million)